Etiometry, Leading Intensive Care Clinical Decision-Support Software, Achieved Record Growth in New Relationships, Beds Served

BOSTON, March 9th, 2021 – Etiometry, a leader in clinical decision-support software for the intensive care environment, today, announced significant business growth and expansion in 2020. Clinicians in the intensive care setting rely on patients’ vital signs to monitor for unexpected health events. Etiometry’s software aggregates the information from multiple sources into one streamlined format to…

Etiometry’s Platform for Clinical Decision Support Software Earns 6th FDA Clearance

BOSTON, December 2nd, 2020 – Etiometry, the leader in clinical decision-support software for critical care, today announced it has received its 6th 510(k) clearance from the US Food and Drug Administration (FDA) adding several new features to the Etiometry Platform. Included are two significant enhancements to their previously cleared patient risk indices. These upgrades provide…

Etiometry Platform Featured in Multiple Research Presentations Accepted at the 16th Annual Meeting of the Pediatric Cardiac Intensive Care Society

BOSTON, December 1st, 2020 – Etiometry, the leader in clinical decision-support software for critical care, has had multiple research projects accepted for presentation at the 16th Annual International Meeting of the Pediatric Cardiac Intensive Care Society (PCICS), which is being held virtually, Dec. 9-11. Etiometry’s clinical decision-support platform includes FDA-cleared risk algorithms, automatically collected comprehensive…

Etiometry Expands its Clinical Decision-Support Software with a NICU Focus

BOSTON, September 1st, 2020 – Etiometry, Inc., the leader in clinical decision-support software for the intensive care environment, is expanding their efforts into neonatal intensive care units. The announcement comes as Etiometry recognizes the work and dedication of clinicians improving the health of the most vulnerable patients during NICU Awareness Month, which kicks-off today. Advancements…

Digital Health Company Earns FDA Clearance for Second Patient Risk Index

BOSTON, December 10th, 2019 – Etiometry Inc., a leading digital health company, today announced the FDA clearance of their second algorithm, the Inadequate Ventilation of Carbon Dioxide (IVCO2) Index™. The IVCO2 Index, along with the already cleared Inadequate Delivery of Oxygen (IDO2) Index™, will be displayed on Etiometry’s critical care software platform which is utilized…

Etiometry Expands Leadership with New CEO

BOSTON, November 7th, 2019 – Etiometry Inc., a leading digital health company which developed a critical care analytics platform, announced today the recent expansion of their leadership team. Shane Cooke, was recently appointed as President and Chief Executive Officer, joining the growing company as it continues to expand its presence in current and new markets.…